Omid Veiseh
Direttore/Membro del Consiglio presso Avenge Bio, Inc.
Provenienza dei contatti di primo grado di Omid Veiseh
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Avenge Bio, Inc.
Avenge Bio, Inc. Pharmaceuticals: MajorHealth Technology Avenge Bio, Inc. is an oncology-focused biotechnology company based in the United States. The American company develops cell-based immunotherapeutic products for the treatment of solid tumors using its proprietary Lococyte™ platform. The platform delivers engineered cells to the local tumor environment, generating high concentrations of immune effector molecules in proximity to the tumor, which initiates a robust, local, and durable systemic immune response while avoiding toxicities associated with systemic immunotherapies. Avenge's most advanced product candidate, AVB-001, produces native IL-2 immunotherapy and is initially being studied in metastatic peritoneal cancers such as ovarian cancer. The company has additional pipeline candidates for the treatment of a wide range of cancers, including pancreatic, lung, and breast cancers. Avenge was founded in 2019 by Paul Kevin Wotton and Michael Thomas Heffernan, with Heffernan serving as CEO since incorporation.
5
| Holding Company | Pharmaceuticals: Major | 5 |
Pana Bio, Inc.
Pana Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Pana Bio, Inc. is an American biotechnology company that focuses on the development and delivery of therapeutic molecules. The CEO of the company is David Yu Zhang.
3
| Holding Company | Miscellaneous Commercial Services | 3 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Omid Veiseh tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
ANTARES PHARMA, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
VERICEL CORPORATION | Pharmaceuticals: Major | Director/Board Member | |
THE GOLDMAN SACHS GROUP, INC. | Investment Banks/Brokers | Private Equity Investor | |
Seaview Securities LLC
Seaview Securities LLC Investment Banks/BrokersFinance Seaview Securities LLC provides investment banking services focused on the life sciences industry. The firm's services include private placements, mergers & acquisitions, financial and business strategy advisory, and underwriting services. The company was founded in January 2002 by Russell L. Pollack and Joseph P. Dougherty and is headquartered in New York, NY. | Investment Banks/Brokers | Founder | |
COLLEGIUM PHARMACEUTICAL, INC. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
CELATOR PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member | |
VELOXIS PHARMACEUTICALS A/S | Pharmaceuticals: Major | Director/Board Member Chairman | |
KELYNIAM GLOBAL, INC. | Medical Specialties | Chief Operating Officer | |
University of Virginia | College/University | Graduate Degree | |
University of Pennsylvania | College/University | Undergraduate Degree | |
FirstMark Capital LLC
FirstMark Capital LLC Investment ManagersFinance FirstMark Capital LLC (FirstMark Capital) is venture capital firm founded by Rick Heitzmann and Amish Jani in 1996. The firm is headquartered in New York. | Investment Managers | Private Equity Analyst | |
University of London | College/University | Undergraduate Degree | |
Trinity College (Connecticut) | College/University | Undergraduate Degree | |
University of South Florida | College/University | Undergraduate Degree | |
Gemin X Pharmaceuticals US, Inc.
Gemin X Pharmaceuticals US, Inc. BiotechnologyHealth Technology Gemin X Pharmaceuticals US Inc. is engaged in the development of cancer therapeutics. It offers mimetic and telomere capping programs, as well as screening, medicinal chemistry, and preclinical development services. The company was founded by Gordon C. Shore in 1998 and is headquartered in Malvern, PA. | Biotechnology | Director/Board Member | |
OCATA THERAPEUTICS INC | Pharmaceuticals: Major | Chief Executive Officer Chairman | |
Astellas Pharma US, Inc.
Astellas Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma US, Inc. manufactures pharmaceutical products. It offers cardiology, dermatology, immunology, infectious diseases, and urology. The firm was founded in 2005 and is headquartered in Northbrook, IL. | Pharmaceuticals: Major | Corporate Officer/Principal | |
CYNATA THERAPEUTICS LIMITED | Biotechnology | Director/Board Member | |
Lehman Brothers, Inc. /Istanbul Division/ | Investment Managers | Corporate Officer/Principal | |
Lundbeck, Inc.
Lundbeck, Inc. Pharmaceuticals: MajorHealth Technology Part of Lundbeck Foundation, Lundbeck, Inc. is a pharmaceutical company that produces pharmaceutical preparations. The company is based in Paramus, NJ. The company was founded by Jeffrey S. Aronin. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Caxton Alternative Management LP
Caxton Alternative Management LP Investment ManagersFinance Caxton Alternative Management LP (do-business-as CAM Capital) is a single-family office which was founded in 2012 by Bruce Kovner following his retirement from Caxton Associates, the macro hedge fund he founded and managed from 1983 to 2011. Headquartered in New York City, CAM Capital manages assets exclusively for entities related to Mr. Kovner and its senior employees. | Investment Managers | Chief Executive Officer | |
Valence Life Sciences LLC
Valence Life Sciences LLC Investment ManagersFinance Valence Life Sciences LLC (Valence Life Sciences) is an venture capital firm founded in 2012 by Rachel Anne Leheny and Eric Wayne Roberts. The firm is headquartered in New York. | Investment Managers | Private Equity Investor | |
Harvard Business School | College/University | Masters Business Admin | |
Kingston Business School | College/University | Masters Business Admin | |
NMD Pharma A/S
NMD Pharma A/S BiotechnologyHealth Technology NMD Pharma ApS engages with the research and preparation of small molecules targeting an undisclosed ion. It offers medical treatment of neuromuscular diseases for patients with chronic muscle wasting diseases such as myasthenia gravis and amyotrophic lateral sclerosis. The company was founded by Ole B?kgaard Nielsen, Thomas Holm Pedersen, and Claus Elsborg Olesen on May 7, 2015 and is headquartered in Aarhus, Denmark. | Biotechnology | Chairman | |
Indalo Therapeutics, Inc.
Indalo Therapeutics, Inc. BiotechnologyHealth Technology Indalo Therapeutics, Inc. operates as a biopharmaceutical firm that develops integrin antagonists for patients suffering from serious fibrotic diseases such as nonalcoholic steatohepatitis (NASH) and idiopathic pulmonary fibrosis (IPF). The company was founded by David Griggs, Williamson Z. Bradford III, Peter Ruminski, and Robert W. Karr and is headquartered in Cambridge, MA. | Biotechnology | Chairman | |
SIGILON THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer | |
IKENA ONCOLOGY, INC. | Biotechnology | Director of Finance/CFO | |
Neurana Pharmaceuticals, Inc.
Neurana Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Neurana Pharmaceuticals, Inc. engages in a biotechnology industry. It focused on the development of drugs to treat neuromuscular disorders. The company was founded in 2013 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
CTx Operations, Inc.
CTx Operations, Inc. BiotechnologyHealth Technology CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA. | Biotechnology | Chairman | |
MOLECULAR TEMPLATES, INC. | Biotechnology | Director/Board Member | |
Palvella Therapeutics, Inc.
Palvella Therapeutics, Inc. BiotechnologyHealth Technology Palvella Therapeutics, Inc. operates as a rare disease biopharmaceutical company. It develops and commercializes pathogenetically targeted therapies for rare genodermatoses with no approved treatments. Its products include QTORIN, PTX-022, PTX-367, and PTX-014. The company was founded by Wesley H. Kaupinen in 2015 and is headquartered in Wayne, PA. | Biotechnology | Director/Board Member | |
SYNLOGIC, INC. | Biotechnology | Director/Board Member | |
Primmune Therapeutics, Inc.
Primmune Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Primmune Therapeutics, Inc. develops small molecules, orally administered toll-like receptor for cancer immunotherapy and tumors. The firm offers treatment and prevention of viral infections. The company was founded by Paulo Rangel, James Appleman, and Stephen Webber in October, 2017 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member | |
KaNDy Therapeutics Ltd.
KaNDy Therapeutics Ltd. BiotechnologyHealth Technology KaNDy Therapeutics Ltd. engages in the provision of a treatment of chronic debilitating female sex-hormone related conditions. Its product is NT-814 a non-hormonal therapy to treat moderate to severe post-menopausal vasomotor symptoms. The company was founded by Dr. Mike Trower and Mary Kerr in 2017 and is headquartered in Stevenage, the United Kingdom. | Biotechnology | Director/Board Member | |
Antios Therapeutics, Inc.
Antios Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Antios Therapeutics, Inc. operates as a biopharmaceutical company devoted to developing therapies for viral diseases. The company was founded by Abel De La Rosa, Doug Mayers and Idean Marvasty on October 30, 2018 and is headquartered in Atlanta, GA. | Pharmaceuticals: Major | Director/Board Member | |
Torus Biosystems, Inc.
Torus Biosystems, Inc. Miscellaneous Commercial ServicesCommercial Services Torus Biosystems, Inc. engages in the provision of biotechnology services. It performs DNA testing for scientific and medical research purposes. The company was founded in 2019 and is headquartered in Brookline, MA. | Miscellaneous Commercial Services | Founder | |
Molecular Templates OpCo, Inc.
Molecular Templates OpCo, Inc. Financial ConglomeratesFinance Molecular Templates OpCo, Inc. provides medical services. The company is headquartered in Austin, TX. | Financial Conglomerates | Director/Board Member | |
K36 Therapeutics, Inc.
K36 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology K36 Therapeutics, Inc. develops small molecule therapeutics. The company is based in Cambridge, MA. The company was founded in 2021. The CEO is Terry Connolly. | Pharmaceuticals: Major | Director/Board Member | |
Nested Therapeutics, Inc.
Nested Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nested Therapeutics, Inc. is a biotechnology company based in Cambridge, MA. The company focuses on discovering and developing novel, targeted, small molecule precision medicine therapies for cancer patients. The company uses mutation clusters to identify druggable pockets and have a platform that utilizes insights from genomics, computational chemistry, proteomics, and AI. Nested Therapeutics aims to advance precision oncology medicine by finding new driver mutations to reach a broader group of patients. The company was founded by Arvin Dar and Klaus Hoeflich. The CEO is Darrin Miles. | Miscellaneous Commercial Services | Director/Board Member | |
BIOHAVEN LTD. | Pharmaceuticals: Major | Director/Board Member |
Statistiche
Distribuzione geografica
Stati Uniti | 42 |
Regno Unito | 4 |
Danimarca | 3 |
Australia | 2 |
Turchia | 2 |
Settori
Health Technology | 31 |
Finance | 11 |
Consumer Services | 8 |
Commercial Services | 4 |
Posizioni
Director/Board Member | 51 |
Independent Dir/Board Member | 18 |
Corporate Officer/Principal | 13 |
Chief Executive Officer | 12 |
President | 9 |
Contatti più connessi
Insiders | |
---|---|
Paul Wotton | 27 |
Michael Heffernan | 23 |
Scott Morenstein | 17 |
Douglas R. Carlson | 9 |
Josh Richardson | 9 |
David Yu Zhang | 3 |
Jeffrey Tabor | 1 |
Robert Britton | 1 |
- Borsa valori
- Insiders
- Omid Veiseh
- Connessioni Società